NATIONAL HEALTHCARE CORP·4

May 7, 6:04 PM ET

ADAMS ROBERT G 4

4 · NATIONAL HEALTHCARE CORP · Filed May 7, 2026

Research Summary

AI-generated summary of this filing

Updated

NHC Director Robert G. Adams Receives 7,500-Share Award

What Happened

  • Robert G. Adams, a director of National Healthcare Corp (NHC), was granted 7,500 stock options on May 7, 2026. The Form 4 reports the acquisition as a derivative award at $0.00 (no cash paid reported at grant).

Key Details

  • Transaction date: 2026-05-07
  • Transaction type: Award/Grant of derivative securities (code A)
  • Amount: 7,500 stock options; reported acquisition price $0.00 and reported value $0
  • Shares owned after transaction: Not specified in the provided filing excerpt
  • Footnote: Options granted under the 2020 Omnibus Equity Incentive Plan; grant and exercise are exempt from Section 16(b) under Rule 16b-3(d)
  • Timeliness: Reported on the same date as the transaction (no late filing indicated)

Context

  • This was an option grant (a compensation award for a director), not an immediate purchase of common stock. Options give the holder the right to buy shares later under plan terms; the filing does not indicate exercise or any immediate sale. Such grants are common for director compensation and are typically routine rather than a direct buy/sell signal.

Insider Transaction Report

Form 4
Period: 2026-05-07
Transactions
  • Award

    Option to Purchase Common Stock [2026 Grant]

    [F1]
    2026-05-07+7,5007,500 total
    Exercise: $171.42From: 2027-05-07Exp: 2031-05-06Common Stock (7,500 underlying)
Holdings
  • Shares of Common Stock - Partnership

    (indirect: General Partner)
    430,341
  • Shares of Common Stock - Trust I

    (indirect: By Trust)
    13,579
  • Option to Purchase Common Stock [2022 Grant]

    Exercise: $69.19From: 2023-05-05Exp: 2027-05-04Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2023 Grant]

    Exercise: $55.75From: 2024-05-04Exp: 2028-05-03Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2024 Grant]

    Exercise: $96.03From: 2025-05-09Exp: 2029-05-08Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2025 Grant]

    Exercise: $94.66From: 2026-05-08Exp: 2030-05-07Common Stock (7,500 underlying)
    7,500
Footnotes (1)
  • [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
Signature
/s/ Robert Adams|2026-05-07

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4